CVS Health Corp. (CVS)
| Market Cap | 111.33B |
| Revenue (ttm) | 271.05B |
| Net Income (ttm) | 7.40B |
| Shares Out | 1.31B |
| EPS (ttm) | 5.62 |
| PE Ratio | 15.76 |
| Forward PE | 11.03 |
| Dividend | $2.00 |
| Dividend Yield | 2.26% |
| Trading Day | May 18 |
| Last Price | $88.51 |
| Previous Close | $84.56 |
| Change ($) | 3.95 |
| Change (%) | 4.67% |
| Day's Open | 86.00 |
| Day's Range | 85.97 - 88.61 |
| Day's Volume | 12,852,295 |
| 52-Week Range | 54.63 - 88.61 |
The fraudulent cards will likely pose an issue as more places require proof of Covid-19 vaccination.
Patient investors should be handsomely rewarded by this combination of growth and value stocks.
The overall impact of the pandemic was a positive one for the company's Q1 results.
Value stocks have made a big comeback this year as investors rotate out of technology and other growth securities amid heightened fears of inflation and higher interest rates. Here we look at the four b...
WOONSOCKET, R.I., May 12, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) announced that COVID-19 vaccine appointments for adolescents ages 12 to 15 are now available for scheduling at more than 5,600 CVS P...
WOONSOCKET, R.I., May 11, 2021 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), today announced an upgrade to its CarePass membership program, with prescription delivery with...
UnitedHealth Group, reported $4.9bn in profits in the first quarter of 2021 while CVS Health reported $2.2bn
The investors were more than happy with CVS' Q1 performance as well as revised guidance, and the stock rose 4%, post the earnings announcement. Now that over 44% of the U.S. population has received at l...
WOONSOCKET, R.I., May 6, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that ...
CVS teams up with U.S. employers to vaccinate working Americans
CVS announced that it would be working with U.S. employers to open up on-site COVID-19 vaccination clinics. Anjalee Khemlani and Chief Medical Officer at CVS Caremark Sree Chaguturu discuss what this in...
Bargains abound for patient long-term investors.
CVS Health (CVS) closed the most recent trading day at $81.12, moving +4.41% from the previous trading session.
Retail pharmacy and health care provider CVS Health Inc. ( CVS , Financial) announced revenue and earnings that edged past analyst estimates on Tuesday.
Before the opening bell on May 4, CVS Health Corp. ( CVS , Financial) released first-quarter 2021 results, wherein both earnings and revenue topped Wall Street's expectations due to solid retail and pha...
CVS Health's (CVS) revenues across all the three operating segments improve in Q1. Increased guidance amid the pandemic scenario is another positive.
CVS Health reported strong first quarter results with revenues at $69 billion, up 3.5% from the same period last year.
CVS Health Corporation (NYSE: CVS) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also raised FY21 EPS guidance above estimates.
As a frontline healthcare company, it is impossible for CVS not to look back to a year ago, when the early stages of COVID lockdowns had store shelves picked bare as consumers panic-bought everything fr...
All of the company's segments delivered solid growth.
CVS Health reported more than $2 billion in first quarter profits thanks to an influx of customers seeking Covid-19 diagnostic tests and vaccines.
CVS Health (CVS) delivered earnings and revenue surprises of 18.60% and 0.96%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CVS Health Corp. (NYSE: CVS) said on Tuesday that its profit and sales came in better than expected in the fiscal first quarter as all of its business segments showed resilience in recent months. On the...
CVS Health Corporation (NYSE: CVS) shares moved higher in the premarket after the company reported better than expected Q1 earnings. Overall revenues increased 3.5% Y/Y to $69.1 billion, driven by growt...
CVS Health Corp reported a 10.5% rise in first-quarter profit on Tuesday, helped in part by higher sales at its drug stores, with more customers seeking COVID-19 tests and vaccinations.
WOONSOCKET, R.I., May 4, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2021.
Some of the stocks that may grab investor focus today are: Wall Street expects CVS Health Corp (NYSE: CVS) to report quarterly earnings at $1.71 per share on revenue of $68.39 billion before the opening...
It's a new month for your money and here are the Chartmaster's top picks for May
Cornerstone Macro's Carter Worth has three charts blooming with opportunity. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Pete Najarian.
We expect CVS Health to likely post revenue and earnings below the street expectations, as a rebound in total procedure volume may result in higher benefit costs, while pricing pressure in the pharmacy ...
WOONSOCKET, R.I., May 3, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced new initiatives to support women's health and wellness in May, including offering no-cost heart health screenings fro...
More than 900 publicly traded companies are scheduled to report March quarter earnings next week, with heavy representation from energy exploration and production companies.
CVS Group PLC (LON:CVSG) galloped 9% higher to 184p at lunchtime after upgrading expectations for full-year revenue and adjusted underlying earnings (EBITDA). The veterinary services provider said sales...
WOONSOCKET, R.I., April 30, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today it has launched an expansion of Project Health, the company's no-cost, community-based screening program, which he...
CVS Group PLC (LON:CVSG) said full-year revenue and adjusted underlying earnings (EBITDA) will top management expectations. The veterinary services provider said sales are remaining strong and there has...
CVS Health (NYSE: CVS) has inaugurated CVS Health Ventures, a corporate venture capital fund aimed at creating partnerships with early-stage companies focused on improving the accessibility and affordab...
The shares of CVS Health Corp (NYSE:CVS) have faced continued pressure at the $78 region, making a few attempts to topple the ceiling over the last few years, including on April 21, when the stock rose ...
WOONSOCKET, R.I., April 29, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the launch of CVS Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with...
WOONSOCKET, R.I., April 29, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it recently began administering COVID-19 vaccines at employer-based vaccination clinics through Return Ready, help...
Given the increasing number of walk-in-clinical appointments and patient visits, CVS Health (CVS), which has a huge PBM client base, is expected to have seen a sequential rebound in Q1 revenues.
In the latest trading session, CVS Health (CVS) closed at $75.75, marking a -0.39% move from the previous day.
The future of commerce is trending in PayPal's favor.
A key driver in the success of the CVS retail segment is the loyalty program which boasts 74 million members who are provided with a variety of rewards, automatic sales prices, and customized coupons.
The stock price of CVS Health looks attractive at current levels of $76. The stock is up 49% from the level of $51 it was at on March 23, 2020, when broader markets made a bottom due to the spread of Co...
WOONSOCKET, R.I., April 21, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that MinuteClinic, the medical clinic inside CVS Pharmacy, is now offering Video Visits for patients in the state ...
CVS Health Corporation (NYSE:CVS) shares have once again run into resistance at the $76.50 level and may be about to move lower. Resistance is a large group of sellers trying to sell at the same price.
WOONSOCKET, R.I., April 20, 2021 /PRNewswire/ -- CVS Health Corporation ("CVS Health") (NYSE:CVS) will hold a conference call with analysts and investors on Tuesday, May 4, 2021, at 8:00 a.m.
All three can be purchased in-person or online, and do not require a prescription.
In the latest trading session, CVS Health (CVS) closed at $75.75, marking a -0.17% move from the previous day.
About CVS
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health in... [Read more...]
| Industry Healthcare Plans | Founded 1963 |
| CEO Larry Merlo | Employees 213,000 |
| Stock Exchange NYSE | Ticker Symbol CVS |
Financial Performance
In 2020, CVS Health's revenue was $268.71 billion, an increase of 4.65% compared to the previous year's $256.78 billion. Earnings were $7.18 billion, an increase of 8.22%.
Analyst Forecasts
According to 27 analysts, the average rating for CVS Health stock is "Buy." The 12-month stock price forecast is 92.40, which is an increase of 4.39% from the latest price.